Tenon Medical receives Nasdaq bid price deficiency notice; stock below $1.00 for 30 days

Tenon Medical, Inc.

Nasdaq letter dated May 7, 2024, citing 30 consecutive business days below $1.00 minimum bid price from Mar 25 to May 6.
Initial 180-day compliance period runs until November 4, 2024, to regain compliance with Bid Price Rule.
If not cured, company may qualify for a second 180-day period if it meets other listing standards and notifies intent to cure.
Company is evaluating options; no immediate impact on listing, but no assurance of regaining compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Tenon Medical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

ule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial

View on SEC.gov

97 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-040903

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.